What else gets checked besides blood sugar?
· 2 min

Vessel damage has three burdens, and sugar is only one of them; that’s why blood pressure and blood fats get checked too. High pressure strains the kidney’s filter and the eye’s capillaries, while blood fats decide the large-vessel side. Looking at all three together has a bigger effect.
Sugar doesn’t act alone in this picture. Two more burdens stand beside it, and all three end up in the same place: the vessel wall. Blood pressure pushes the vessel from inside; blood fats settle into the wall itself. Diabetes makes both jobs easier.
Picturing pressure as a bicycle tire helps. A tire setting out at high pressure wears at its thinnest point. That thin point in the body is the kidney’s filter units and the capillary web behind the eye. Wear eases on both sides when pressure drops, measured in a broad review pooling forty studies.
Blood fats work another way. Particles slipping under the vessel lining collect there and build plaque; the heart article covers the process itself. This side concerns the heart, brain, and leg circulation. Cholesterol-lowering treatments were found to cut vascular events at the same rate in people with diabetes as in those without.
| Burden | Where its weight is felt most | What monitoring involves |
|---|---|---|
| Glucose | Eye, kidney, nerve | Daily measurements and HbA1c |
| Blood pressure | Kidney filter, eye capillaries | Arm cuff reading |
| Blood fats | Heart, brain, leg vessels | Lipid panel |
The three share one more trait: none makes itself felt. Neither high pressure nor high blood fats has a daily symptom; both show in an arm reading and a blood test. Narrowing vessels’ best-known sign is in the legs: your calf seizing as you walk back from the store, easing when you stop and wait.
Handling them separately is one thing, together another. A study in a group leaking albumin into the urine tested just that. Targeting glucose, pressure, and blood fats at once left vascular events and the death rate clearly lower than care focused on one burden. In the long years since, the gap didn’t close.
Giving numbers has no point, since targets are built person by person. What matters is this: a lab result’s lines aren’t independent. If the sugar line improves while blood pressure and blood fats stay put, two-thirds of the vessel-side load still sits in place.
The list doesn’t end there: smoking, and how the kidney works. The kidney isn’t only a target organ; it’s also a measure. When filtering slows, many medications stay in the body longer, managing blood pressure gets harder, and treatment choice shifts accordingly. So the filtering rate sits beside the blood pressure line.
For you, this comes down to something simple. Why diabetes monitoring isn’t only measuring sugar is answered here; the blood pressure cuff and the blood fat line weren’t added to the list for show. But the main burdens are these three.
Sources
- Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A. Blood Pressure Lowering in Type 2 Diabetes: A Systematic Review and Meta-analysis. JAMA. 2015;313(6):603–615. doi:10.1001/jama.2014.18574
- Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet. 2008;371(9607):117–125. doi:10.1016/S0140-6736(08)60104-X
- Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes. N Engl J Med. 2008;358(6):580–591. doi:10.1056/NEJMoa0706245
- American Diabetes Association Professional Practice Committee. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Supplement_1):S216–S245. doi:10.2337/dc26-S010. PMID: 41358899.
- Türkiye Endokrinoloji ve Metabolizma Derneği (TEMD). Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu-2026. 17. Baskı. TEMD; 2026. ISBN 978-625-99759-8-6